BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

East Midlands' bioscience knowledge exchange initiative launched

Nottingham, 22nd November 2005 – bioKneX, the new bioscience knowledge exchange initiative for the East Midlands, held its official launch today at BioCity Nottingham, UK.  To an audience of more than 100 delegates, Peter Jones, Pro-Vice Chancellor for Research and Business Development at Nottingham Trent University, highlighted the research strengths within the East Midlands’ universities.   Paul Harper, a leading bioscience entrepreneur, shared his views on how effective knowledge exchange can fuel commercialisation and economic development in the region.
 
The aim of bioKneX is to enhance collaboration and partnering between the region’s universities, industry and education system, and to publicise bioscience excellence in the region. The initiative has been established following the award of funding from the HEFCE to Nottingham Trent University, the University of Nottingham and the University of Leicester with further funding from the East Midlands Development Agency (emda) and the EU.
 
In his opening talk, Steve Beasley, CEO of bioKneX, commented, “The academic strengths of the region have been highlighted by this year’s award of ‘Science City’ status to Nottingham.  bioKneX will help to foster and promote these strengths and help attract further research funding into the East Midlands’ universities. 
 
Through effective knowledge exchange and collaborations we shall also identify investment opportunities that will bring together researchers, commerce, education, investors and suppliers to encourage the growth of the bioscience competence and community in the region.”
 
Ends
 
 
Dr Paul Harper, Chairman RegenTec Ltd, Dr Steve Beasley, CEO bioKneX and Professor Peter Jones, Pro Vice-Chancellor Nottingham Trent University, at the launch of bioKneX. For high resolution images please contact Dr Marc Egelhofer, Northbank Communications, +44 (0) 1260 296 500, m.egelhofer@northbankcommunications.com  

Media enquiries:
Dr Marc Egelhofer, Northbank Communications
m.egelhofer@northbankcommunications.com
T +44 (0) 1260 296 500
 
Contact at bioKneX:
Dr Steve Beasley
Steve.Beasley@bioknex.org
T +44 (0) 115 912 4475
 
About bioKneX:
bioKneX is the bioscience knowledge exchange for the East Midlands, established in 2004 to enhance collaboration and partnering between the region’s universities, industry and education system, and to publicise bioscience excellence in the region.  Initial funding for bioKneX resulted from a successful collaborative bid by Nottingham Trent University, the University of Nottingham and the University of Leicester to the Higher Education Funding Council for England (HEFCE).  This funding, awarded under the Higher Education Innovations Fund (HEIF) to establish the knowledge exchange has since been matched by emda and the European Regional Development Framework (ERDF) under the Innovative Actions programme.
 
bioKneX has a full-time staff of 5 based at offices in BioCity Nottingham.  A satellite office in Leicester is planned.  The Company’s CEO, Dr Steve Beasley, has over 24 years experience in the pharmaceutical and biotechnology industry, including Pfizer, Shell, Chiroscience and De Novo Pharmaceuticals.
 
For more information please visit www.bioknex.org.
 
  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreements

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road, Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.